At the close of October, PLoS Medicine published 5 new articles, including the monthly editorial:
The PLoS Medicine editors reflect on recent research and analysis that highlight the need to fully evaluate rapid diagnostics.
Using Mendelian randomization, Roman Pfister and colleagues demonstrate a potentially causal link between low levels of B-type natriuretic peptide (BNP), a hormone released by damaged hearts, and the development of type 2 diabetes.
Based on a statistical analysis of 111 facilities in Africa, Asia, and Latin America, Benjamin Chi and colleagues develop a standard loss-to-follow-up (LTFU) definition that can be used by HIV antiretroviral programs worldwide.
Justin Lessler and colleagues describe a method that estimates the fraction of a population accessible to vaccination activities and apply it to measles vaccination in three African countries: Ghana, Madagascar, and Sierra Leone.
Valentina Gallo and colleagues provide detailed guidance for authors to improve their reporting of epidemiological studies involving biomarkers. The guidance is a Molecular Epidemiology extension of the STROBE Statement.